Amgen Announces Bemarituzumab’s Successful Phase 3 Results in FGFR2b+ Gastric Cancer

Amgen Inc. (NASDAQ:AMGN) is among the 11 Best GLP-1 and Weight Loss Stocks to Invest in. Amgen Inc. (NASDAQ:AMGN) reported that the Phase 3 FORTITUDE-101 trial achieved its primary endpoint. It proved a clinically meaningful and statistically significant improvement in overall survival for patients with FGFR2b-overexpressing, metastatic, or unresectable gastric/gastroesophageal junction cancer treated with bemarituzumab plus chemotherapy (mFOLFOX6). The treatment outperformed chemotherapy alone for non-HER2-positive individuals in this first-line scenario. The threshold for FGFR2b overexpression was ≥10% IHC staining of tumor cells.

Amgen Announces Bemarituzumab's Successful Phase 3 Results in FGFR2b+ Gastric Cancer

A pharmacist filling a prescription for a complex drug developed by the company.

Gastric cancer is the world’s fifth greatest cause of cancer death, accounting for approximately 650,000 fatalities per year. The majority of diagnoses come at an advanced stage, which limits the effectiveness of treatment. Jay Bradner, M.D. of Amgen Inc. (NASDAQ:AMGN), pointed out the significance of this advancement in focused therapy. Ocular toxicity, such as punctate keratitis and dry eye, was seen in the bemarituzumab group, which was comparable with previous research but more common. The trial was created in collaboration with Zai Lab, which has regional rights in China and adjacent areas. Results of an additional Phase 3 trial including nivolumab are anticipated in H2 2025. It is ranked fifth on our list of the Best Weight Loss Stocks.

While we acknowledge the risk and potential of AMGN as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than AMGN and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 10 High-Growth EV Stocks to Invest In and 13 Best Car Stocks to Buy in 2025.

Disclosure. None.